Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: The TIME2 randomized controlled trial

JAMA

Volumn 307, Issue 22, 2012, Pages 2383-2389

  Davies, Helen E ^a   Mishra, Eleanor K ^b   Kahan, Brennan C ^c   Wrightson, John M ^b,d   Stanton, Andrew E ^e   Guhan, Anur ^f,g   Davies, Christopher W H ^h   Grayez, Jamal ⁱ   Harrison, Richard ^j   Prasad, Anjani ^k   Crosthwaite, Nicola ^b   Lee, Y C Gary ^l   Davies, Robert J O ^b,d   Miller, Robert F ^m   Rahman, Najib M ^b,d  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e GREAT WESTERN HOSPITAL   (United Kingdom)

^f JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^g AYR HOSPITAL   (United Kingdom)

^h ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

ⁱ Horton Hospital   (United Kingdom)

^j UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

^k BUCKINGHAMSHIRE HEALTHCARE NHS TRUST   (United Kingdom)

^l UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^m UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; TALC;

AGED; ARTICLE; ASYMPTOMATIC DISEASE; CATHETER OCCLUSION; CAUSE OF DEATH; CELLULITIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPNEA; FEMALE; FOLLOW UP; HUMAN; INDWELLING CATHETER; INTERMETHOD COMPARISON; LENGTH OF STAY; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORTALITY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PLEURA MESOTHELIOMA; PLEURODESIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SCREENING TEST; SURGICAL DRAINAGE; TUBE; VISUAL ANALOG SCALE; CATHETERIZATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PLEURA EFFUSION; TREATMENT OUTCOME; WOUND DRAINAGE;

AGED; CATHETERIZATION; CATHETERS, INDWELLING; DRAINAGE; DYSPNEA; FEMALE; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; TALC; TREATMENT OUTCOME;

EID: 84862266234     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.5535     Document Type: Article

References (24)

1. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ; BTS Pleural Disease Guideline Group. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(suppl 2):ii32-ii40.
2. Rodrǐguez-Panadero F, Borderas Naranjo F, López Mejîas J. Pleural metastatic tumours and effusions: frequency and pathogenic mechanisms in post-mortem series. Eur Respir J. 1989;2(4):366-369.
3. Ferlay JSH, Bray F, Forman D, Mathers C, Parkin DM, eds. Cancer incidence and mortality worldwide [webpage]. World Health Organization, International Agency for Research on Cancer; 2008. v1.2. CancerBase No. 10. http://globocan.iarc.fr. Accessed November 11, 2011.
4. Cancer statistics registrations: registrations of cancer diagnosed in 2009, England. MB1 40 ed. London, England: Office for National Statistics, Stationary Office; 2011.
5. Burrows CM, Mathews WC, Colt HG. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest. 2000;117(1):73-78. (Pubitemid 30053623)
6. Tan C, Sedrakyan A, Browne J, Swift S, Treasure T. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg. 2006;29(5):829-838.
7. Dresler CM, Olak J, Herndon JE II, et al; Cooperative Groups Cancer and Leukemia Group B; Eastern Cooperative Oncology Group; North Central Cooperative Oncology Group; Radiation Therapy Oncology Group. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. 2005;127(3):909-915.
8. Van Meter ME, McKee KY, Kohlwes RJ. Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med. 2011;26(1):70-76.
9. Janes SM, Rahman NM, Davies RJ, Lee YC. Catheter-tract metastases associated with chronic indwelling pleural catheters. Chest. 2007;131(4):1232-1234. (Pubitemid 46608729)
10. Tremblay A, Mason C, Michaud G. Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis. Eur Respir J. 2007;30(4):759-762. (Pubitemid 351194838)
11. Antevil JL, Putnam JB Jr. Talc pleurodesis for malignant effusions is preferred over the pleurx catheter (pro position). Ann Surg Oncol. 2007;14(10):2698-2699.
12. Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest. 2006;129(2):362-368. (Pubitemid 43289856)
13. Putnam JB Jr, Light RW, Rodriguez RM, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer. 1999;86(10):1992-1999.
14. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975;31(1):103-115.
15. Musani AI, Haas AR, Seijo L, Wilby M, Sterman DH. Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters. Respiration. 2004;71(6):559-566. (Pubitemid 40091427)
16. Bausewein C, Farquhar M, Booth S, Gysels M, Higginson IJ. Measurement of breathlessness in advanced disease: a systematic review. Respir Med. 2007;101(3):399-410. (Pubitemid 46205909)
17. Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD. 2005;2(1):105-110. (Pubitemid 40776230)
18. Maringwa J, Quinten C, King M, et al EORTC PROBE Project and Brain Cancer Group. Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Ann Oncol. 2011;22(9):2107-2112.
19. Kahan BC, Morris TP. Improper analysis of trials randomised using stratified blocks or minimisation. Stat Med. 2012;31(4):328-340.
20. White IR, Thompson SG. Adjusting for partially missing baseline measurements in randomized trials. Stat Med. 2005;24(7):993-1007. (Pubitemid 40426000)
21. Royston P, Parmar MK. The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. Stat Med. 2011;30(19):2409-2421.
22. Fysh ET, Waterer GW, Kendall P, et al. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion [published online March 8, 2012]. Chest. doi:10.1378/chest.11-2657.
23. Olden AM, Holloway R. Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis. J Palliat Med. 2010;13(1):59-65.
24. Putnam JB Jr, Walsh GL, Swisher SG, et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg. 2000;69(2):369-375. (Pubitemid 30125561)